Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:02 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 44.96 USD | -0.04% |
|
-7.05% | -52.85% |
| 09-08 | S&P 500 falls as AI worries hit software makers | RE |
| 09-08 | Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup | DJ |
| Market Cap | 65.16B 56.07B 52.79B 48.1B 90B 6,200B 90.36B 626B 242B 3,159B 245B 239B 10,007B | P/E 2026 * |
17x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 73.87B 63.57B 59.86B 54.54B 102B 7,030B 102B 709B 274B 3,581B 277B 271B 11,345B | EV / Sales 2026 * |
3.46x | EV / Sales 2027 * | 3.17x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Tradegate
| BSX | Real-time | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
London S.E.
| 0HOY | Delayed | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time | |
|
CBOE
| Real-time |
Last Transcript : Boston Scientific Corporation
| 1 day | -0.04% | ||
| 1 week | -7.05% | ||
| Current month | -6.92% | ||
| 1 month | -8.82% | ||
| 3 months | -8.17% | ||
| 6 months | -37.47% | ||
| Current year | -52.85% |
| 1 week | 44.85 |  | 48.06 |
| 1 month | 44.85 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 105.72 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | -7.05% | -58.41% | -16.54% | 65.16B | |
| +0.44% | -0.47% | +25.56% | +16.87% | 224B | |
| -0.19% | -2.41% | +5.41% | -17.52% | 144B | |
| +0.88% | -5.01% | -24.45% | +18.45% | 125B | |
| -0.47% | -0.62% | -20.11% | -14.78% | 50.05B | |
| -0.62% | -5.11% | +7.99% | +16.35% | 49.67B | |
| -1.43% | -4.39% | +14.65% | +26.98% | 40.81B | |
| +0.47% | -1.79% | +34.70% | +53.59% | 39.77B | |
| -2.87% | -3.87% | +108.72% | +29.45% | 30.96B | |
| -0.50% | -4.73% | -21.22% | +48.67% | 31.47B | |
| Average | -0.40% | -2.69% | +7.29% | +16.15% | 80.06B | |
| Weighted average by Cap. | -0.01% | -2.39% | +4.64% | +10.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.33B 18.36B 17.28B 15.75B 29.47B 2,030B 29.58B 205B 79.17B 1,034B 80.1B 78.36B 3,276B | 22.31B 19.19B 18.07B 16.47B 30.81B 2,123B 30.94B 214B 82.79B 1,081B 83.76B 81.94B 3,426B |
| Net income | 3.8B 3.27B 3.08B 2.8B 5.24B 361B 5.26B 36.45B 14.09B 184B 14.25B 13.94B 583B | 3.68B 3.17B 2.98B 2.72B 5.08B 350B 5.1B 35.35B 13.66B 178B 13.82B 13.52B 565B |
| Net Debt | 8.72B 7.5B 7.06B 6.44B 12.04B 829B 12.09B 83.71B 32.35B 423B 32.73B 32.02B 1,339B | 5.45B 4.69B 4.42B 4.02B 7.53B 519B 7.56B 52.35B 20.23B 264B 20.47B 20.03B 837B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | US$44.96 | -0.04% | 17,979,923 |
| 08/09/26 | US$44.98 | -5.90% | 29,028,776 |
| 04/09/26 | US$47.80 | +1.81% | 15,504,234 |
| 03/09/26 | US$46.95 | -2.94% | 19,732,249 |
| 02/09/26 | US$48.37 | +0.60% | 17,017,972 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
